Newpage Solutions Achieves Net Zero Status - Pharma Get's a Sustainable, Low-Risk Tech Partner for 2026 and Beyond

Newpage Solutions, a global technology partner to the life sciences and healthcare industries, today announced that it has officially achieved Net Zero emissions for Scope 1 and 2, marking a major milestone in sustainable digital transformation. This achievement positions Newpage as one of the few top technology partners that pharmaceutical, biotechnology, and medical device companies can confidently include in their sustainability and ESG supply chain audits.

A Sustainable Partner for a Sustainable Industry

Pharma and life sciences organizations are under increasing pressure to meet ambitious Net Zero and ESG targets. Vendor selection now plays a vital role in their sustainability reporting, with IT and technology partners contributing significantly to Scope 3 emissions. By partnering with Newpage, companies gain a Net Zero-certified technology vendor-one whose operations already meet global science-based sustainability standards.

In the words of Syed Arshad, CEO of Newpage Solutions,

"We don't just help life sciences companies innovate; we help them innovate responsibly. Our Net Zero status gives our clients the assurance that their digital transformation is aligned with their sustainability commitments."



Built, Not Bought: How Newpage Engineered Its Net Zero Transition

Unlike many companies that rely on offsets or external consultants, Newpage engineered its Net Zero transformation from within. The company's distributed team model, spanning 10 countries, eliminates emissions from physical offices and daily commutes. Its cloud-first, energy-efficient architecture leverages AWS and Azure Green Zones to minimize infrastructure-related emissions.

"Every decision - from how we code to how we collaborate - was redesigned to reduce our carbon footprint," said Kevin Sprague, CTO of Newpage Solutions.
"We call it 'Net Zero by Design.' Sustainability isn't an afterthought; it's part of the engineering DNA."

Key actions included:

Eliminating office and commuting emissions through a fully remote work model.

Using carbon-efficient cloud services and autoscaling architectures to prevent energy overuse.

Adopting device lifecycle management and sustainable procurement policies.

Conducting a full carbon audit across operations, verified by independent third-party assessors.



Why It Matters for Pharma and Biotech

The pharmaceutical and biotechnology sectors are increasingly measured by the sustainability of their supply chain ecosystems. As companies pursue carbon-neutral manufacturing, green R&D operations, and energy-efficient labs, the technology layer often remains an overlooked source of emissions.

Newpage's Net Zero achievement directly supports pharma clients in meeting sustainability objectives by providing:

Net Zero technology solutions for pharma - helping reduce emissions linked to software delivery and IT infrastructure.

Sustainable IT for life sciences - built on carbon-efficient, autoscaling cloud systems.

Green digital transformation in pharmaceuticals - ensuring digital health and AI innovation align with ESG goals.

Eco-friendly AI and automation for life sciences - delivering intelligent systems that optimize energy use and reduce waste.

Decarbonization in pharma IT operations - measurable, traceable carbon reduction across digital ecosystems.

This enables companies like Pfizer, Novartis, or emerging biotech startups to demonstrate responsible vendor partnerships in their sustainability audits and public ESG reports.



Scope 3 and the Road Ahead

With Scope 1 and 2 emissions now at zero, Newpage's next mission is to tackle Scope 3 emissions-those embedded in its supply chain, vendor relationships, and software delivery pipelines.
Plans include:

Collaborating with cloud partners to improve upstream sustainability.

Auditing computer workloads for carbon efficiency.

Hosting sustainability awareness programs for internal teams.

Launching a public sustainability dashboard by 2026 to share quarterly impact data.

By 2030, Newpage aims to achieve Net Zero across its entire value chain, guided by the Science Based Targets initiative (SBTi) framework.



A Partner Built for Responsible Innovation

Newpage's technology offerings-spanning AI and automation, CRM and Martech, cloud and integration, digital health platforms, and testing automation-are now powered by sustainable operations that align with the ESG priorities of modern life sciences organizations.

Driven by its core belief that technology should advance human life responsibly, Newpage designs every solution to create a measurable impact-on people, on health outcomes, and on the planet. From developing energy-efficient cloud solutions for healthcare and biotech to building sustainable software architectures that support large-scale medical data, Newpage ensures that innovation contributes both to scientific progress and environmental stewardship.

"Becoming Net Zero isn't the end of our journey," said Arshad.
"It's the foundation for everything we build next - technology that's good for people, and good for the planet."

🌐 Learn more: https://newpage.io/sustainable-digital-transformation-life-sciences/
📩 Contact: info@newpage.io

Newpage Solutions Inc.,
601 Brickell Key Drive,
Suite 700,
Miami, Florida - 33131

Newpage Solutions is a global digital innovation partner for the life sciences and healthcare industries, with teams across 10 countries and experience delivering over 200 projects in 27+ markets. The company specializes in AI and data platforms, marketing technology, cloud-native engineering, and connected health solutions, serving pharmaceutical, biotech, and MedTech clients.

In addition to delivering cutting-edge technology solutions, Newpage is a trusted partner to global life sciences organizations set up and scale Offshore Development Centers (ODCs) and Global Capability Centers (GCCs) - enabling faster innovation, cost efficiency, and access to highly skilled, domain-ready talent. These AI-driven capability centers are designed to provide domain-ready talent, sustainable engineering practices, and deep alignment with regulatory priorities.

Its mission is to improve human health through technology-responsibly, intelligently, and sustainably.

This release was published on openPR.